Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

A hybrid radioactive and fluorescent tracer for sentinel node biopsy in penile carcinoma as a potential replacement for blue dye.

Brouwer OR, van den Berg NS, Mathéron HM, van der Poel HG, van Rhijn BW, Bex A, van Tinteren H, Valdés Olmos RA, van Leeuwen FW, Horenblas S.

Eur Urol. 2014 Mar;65(3):600-9. doi: 10.1016/j.eururo.2013.11.014.

PMID:
24355132
2.

Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.

Brouwer OR, Buckle T, Vermeeren L, Klop WM, Balm AJ, van der Poel HG, van Rhijn BW, Horenblas S, Nieweg OE, van Leeuwen FW, Valdés Olmos RA.

J Nucl Med. 2012 Jul;53(7):1034-40. doi: 10.2967/jnumed.112.103127.

3.

Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid.

van den Berg NS, Brouwer OR, Schaafsma BE, Mathéron HM, Klop WM, Balm AJ, van Tinteren H, Nieweg OE, van Leeuwen FW, Valdés Olmos RA.

Radiology. 2015 May;275(2):521-9. doi: 10.1148/radiol.14140322.

PMID:
25521776
4.

Multimodal surgical guidance towards the sentinel node in vulvar cancer.

Mathéron HM, van den Berg NS, Brouwer OR, Kleinjan GH, van Driel WJ, Trum JW, Vegt E, Kenter G, van Leeuwen FW, Valdés Olmos RA.

Gynecol Oncol. 2013 Dec;131(3):720-5. doi: 10.1016/j.ygyno.2013.09.007.

PMID:
24051219
5.

Added value of the hybrid tracer indocyanine green-99mTc-nanocolloid for sentinel node biopsy in a series of patients with different lymphatic drainage patterns.

Frontado LM, Brouwer OR, van den Berg NS, Mathéron HM, Vidal-Sicart S, van Leeuwen FW, Valdés Olmos RA.

Rev Esp Med Nucl Imagen Mol. 2013 Jul-Aug;32(4):227-33. doi: 10.1016/j.remn.2013.02.004.

6.

Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid.

van den Berg NS, Brouwer OR, Klop WM, Karakullukcu B, Zuur CL, Tan IB, Balm AJ, van den Brekel MW, Valdés Olmos RA, van Leeuwen FW.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1128-36. doi: 10.1007/s00259-012-2129-5.

PMID:
22526966
7.

Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer.

KleinJan GH, van den Berg NS, Brouwer OR, de Jong J, Acar C, Wit EM, Vegt E, van der Noort V, Valdés Olmos RA, van Leeuwen FW, van der Poel HG.

Eur Urol. 2014 Dec;66(6):991-8. doi: 10.1016/j.eururo.2014.07.014.

PMID:
25092539
8.

Feasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients.

Christensen A, Juhl K, Charabi B, Mortensen J, Kiss K, Kjær A, von Buchwald C.

Ann Surg Oncol. 2016 Feb;23(2):565-72.

9.

Comparison of Real-Time Fluorescent Indocyanine Green and (99m)Tc-Nanocolloid Radiotracer Navigation in Sentinel Lymph Node Biopsy of Penile Cancer.

Markuszewski M, Polom W, Cytawa W, Czapiewski P, Lass P, Matuszewski M.

Clin Genitourin Cancer. 2015 Dec;13(6):574-80. doi: 10.1016/j.clgc.2015.06.005.

PMID:
26231913
10.

Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.

Verbeek FP, Tummers QR, Rietbergen DD, Peters AA, Schaafsma BE, van de Velde CJ, Frangioni JV, van Leeuwen FW, Gaarenstroom KN, Vahrmeijer AL.

Int J Gynecol Cancer. 2015 Jul;25(6):1086-93. doi: 10.1097/IGC.0000000000000419.

11.

Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer.

Brouwer OR, Klop WM, Buckle T, Vermeeren L, van den Brekel MW, Balm AJ, Nieweg OE, Valdés Olmos RA, van Leeuwen FW.

Ann Surg Oncol. 2012 Jun;19(6):1988-94. doi: 10.1245/s10434-011-2180-7.

12.

Penile lymphoscintigraphy for sentinel node identification.

Valdés Olmos RA, Tanis PJ, Hoefnagel CA, Jansen L, Nieweg OE, Meinhardt W, Horenblas S.

Eur J Nucl Med. 2001 May;28(5):581-5.

PMID:
11383862
13.
14.

Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer.

van der Poel HG, Buckle T, Brouwer OR, Valdés Olmos RA, van Leeuwen FW.

Eur Urol. 2011 Oct;60(4):826-33. doi: 10.1016/j.eururo.2011.03.024.

PMID:
21458154
15.

Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients.

Buckle T, Brouwer OR, Valdés Olmos RA, van der Poel HG, van Leeuwen FW.

J Nucl Med. 2012 Jul;53(7):1026-33. doi: 10.2967/jnumed.111.098517.

16.

Multimodal hybrid imaging agents for sentinel node mapping as a means to (re)connect nuclear medicine to advances made in robot-assisted surgery.

KleinJan GH, van den Berg NS, de Jong J, Wit EM, Thygessen H, Vegt E, van der Poel HG, van Leeuwen FW.

Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1278-87. doi: 10.1007/s00259-015-3292-2.

17.

Fluorescence guided surgery and tracer-dose, fact or fiction?

KleinJan GH, Bunschoten A, van den Berg NS, Olmos RA, Klop WM, Horenblas S, van der Poel HG, Wester HJ, van Leeuwen FW.

Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1857-67. doi: 10.1007/s00259-016-3372-y.

18.
19.

Penile cancer: Developments in sentinel lymph node biopsy for penile cancer.

Watkin N, La-Touche S.

Nat Rev Urol. 2014 Mar;11(3):135-7. doi: 10.1038/nrurol.2014.34. No abstract available.

PMID:
24567086
20.

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.

Breast Cancer. 2000 Jan;7(1):87-94.

PMID:
11029778

Supplemental Content

Support Center